» Go to news main
Molly Appeal paves the way to precision cancer treatment
Posted by Melanie Jollymore on
November 24, 2017
in
News
2017 Molly Appeal lead researchers (left to right) Wenda Greer, Zhaolin Xu and Paola Marignani. (Group photos by Danny Abriel; additional photos courtesy Dalhousie Medical Research Foundation)
A group of Dalhousie Medical School researchers is spearheading a new initiative to develop personalized cancer treatments, with support from Dalhousie Medical Research Foundation’s 2017-18 Molly Appeal.
“Every person’s cancer is as unique as their fingerprints,” says Dr. Paola Marignani, an internationally known cancer researcher and professor in Dalhousie’s Department of Biochemistry & Molecular Biology who’s leading this year’s Molly Appeal research initiative.
Read more on Dal News.
Recent News
- Big research, little time: Medical neuroscience student wins 3 Minute Thesis finals
- Black Health Primer aims for inclusive healthcare
- 54th annual event was hosted Feb. 17, 2024, to sold out crowds
- Dalhousie University's Master of Physician Assistant Studies Program
- Association of Faculties of Medicine of Canada recognizes Dalhousie learners, faculty, and staff
- Dal Med student helps African Nova Scotian youth discover a passion for STEM
- New national program supports mental health of doctors and trainees with daily messages
- Dalhousie researchers navigate world of anesthesia in microgravity